“Semax treats stroke, migraine, or severe facial pain.”

01 · Answer

Not established

FDA staff found insufficient evidence of effectiveness for cerebral ischemia, migraine, or trigeminal neuralgia. The two stroke studies listed here have important design and comparison limits.

What kind of evidence this is

No reliable human outcome evidence. No reliable study in people shows the health outcome in this statement.

What this answer covers

The uses reviewed by FDA in 2026; this does not assess every possible research question. This answer covers only the named molecule and finished product. It also covers the product form and how people used it. The study limits include who took part, what was used for comparison, what changed, and how long the study lasted.

Question type

Clinical outcomes. What a study measured about people's health, symptoms, or ability to function.